The 340B Drug Pricing Program allows certain hospitals and clinics to buy medications given to outpatients at a discount, ...

While the 10% tariff on Chinese goods won’t have too much impact on branded drugs, generics are struggling to pivot.

Pfizer and Merck, ostensibly beleaguered drugmakers, have seen their shares battered despite reporting strong earnings.

The companies raised prices a median 4%, though some drugs will cost thousands of dollars more.

Drugmakers hope to see efforts that focus more on cracking down on pharmacy benefit managers while promoting drug innovation ...

Drugmakers are growing frustrated with the National Health Service after a clawback tax unexpectedly soared, with ...

AstraZeneca is asking a court to immediately stop generic drugmakers from their plans to make and sell generic forms of ...

New licensing Guidelines issued by the National Institutes of Health at the end of the Biden Administration could harm ...

B Health and two safety-net hospitals want to help the government prove that drugmakers are required to give upfront ...

U.S. hospitals and generic drugmakers urge President Trump to exempt medical goods from new tariffs on Chinese imports. They warn that these tariffs could cause medicine shortages and increase prices.

President Donald Trump is facing pressure from U.S. hospitals and generic drugmakers to exempt medical goods from his new ...

Following rumblings of a private equity bidding war late last year, Bain Capital has emer | Bain Capital is laying out 510 ...